Chemotherapy for ovarian cancer--a consensus statement on standard practice.
Adams
M
M
Calvert
A H
AH
Carmichael
J
J
Clark
P I
PI
Coleman
R E
RE
Earl
H M
HM
Gallagher
C J
CJ
Ganesan
T S
TS
Gore
M E
ME
Graham
J D
JD
Harper
P G
PG
Jayson
G C
GC
Kaye
S B
SB
Ledermann
J A
JA
Osborne
R J
RJ
Perren
T J
TJ
Poole
C J
CJ
Radford
J A
JA
Rustin
G J
GJ
Slevin
M L
ML
Smyth
J F
JF
Thomas
H
H
Wilkinson
P M
PM
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D016190:Carboplatin / Q000008:administration & dosage; D002945:Cisplatin / Q000008:administration & dosage; D003520:Cyclophosphamide / Q000008:administration & dosage; D005260:Female; D017408:Guidelines as Topic; D006801:Humans; D010051:Ovarian Neoplasms / Q000188:drug therapy*; D017239:Paclitaxel / Q000008:administration & dosage; D016032:Randomized Controlled Trials as Topic
D003520:Cyclophosphamide; D016190:Carboplatin; D017239:Paclitaxel; D002945:Cisplatin